A GDF 5 Point Mutation Strikes Twice-Causing BDA 1 and SYNS 2
暂无分享,去创建一个
S. Mundlos | J. Sharpe | S. Doelken | J. Nickel | J. Hecht | P. Seemann | J. Zimmer | K. Dathe | Elisa Degenkolbe | C. Reissner | F. Plöger | Jana König | Maria Walther | J. Raspopovic
[1] L. Deng,et al. Rs143383 in the Growth Differentiation Factor 5 (GDF5) Gene Significantly Associated with Osteoarthritis (OA)-A Comprehensive Meta-analysis , 2013, International journal of medical sciences.
[2] J. Nickel,et al. Promiscuity and specificity in BMP receptor activation , 2012, FEBS letters.
[3] L. Reynard,et al. Genetics and epigenetics of osteoarthritis. , 2012, Maturitas.
[4] W. Sebald,et al. New insights into the molecular mechanism of multiple synostoses syndrome (SYNS): Mutation within the GDF5 knuckle epitope causes noggin‐resistance , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[5] J. Sharpe,et al. Preparation of mouse embryos for optical projection tomography imaging. , 2011, Cold Spring Harbor protocols.
[6] S. Mundlos,et al. Mechanisms of digit formation: Human malformation syndromes tell the story , 2011, Developmental dynamics : an official publication of the American Association of Anatomists.
[7] A. Nohe,et al. Bone morphogenetic proteins: a critical review. , 2011, Cellular signalling.
[8] L. Racacho,et al. Mutations in GDF5 presenting as semidominant brachydactyly A1 , 2010, Human mutation.
[9] Frank P Luyten,et al. GDF5 deficiency in mice is associated with instability-driven joint damage, gait and subchondral bone changes , 2010, Annals of the rheumatic diseases.
[10] S. Mundlos,et al. Mutations in GDF5 Reveal a Key Residue Mediating BMP Inhibition by NOGGIN , 2009, PLoS genetics.
[11] S. Mundlos. The brachydactylies: a molecular disease family , 2009, Clinical genetics.
[12] A. Kotzsch,et al. Crystal structure analysis reveals a spring‐loaded latch as molecular mechanism for GDF‐5–type I receptor specificity , 2009, The EMBO journal.
[13] P. Robinson,et al. The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease. , 2008, American journal of human genetics.
[14] Bernhard Schmierer,et al. TGFβ–SMAD signal transduction: molecular specificity and functional flexibility , 2007, Nature Reviews Molecular Cell Biology.
[15] H. Masuya,et al. A novel dominant-negative mutation in Gdf5 generated by ENU mutagenesis impairs joint formation and causes osteoarthritis in mice. , 2007, Human molecular genetics.
[16] S. Mundlos,et al. A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN. , 2007, American journal of human genetics.
[17] C. Tabin,et al. Generation of transgenic tendon reporters, ScxGFP and ScxAP, using regulatory elements of the scleraxis gene , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.
[18] Qinbo Yang,et al. A novel mutation in GDF5 causes autosomal dominant symphalangism in two Chinese families , 2006, American journal of medical genetics. Part A.
[19] M. Gossen,et al. A protocol for combined Photinus and Renilla luciferase quantification compatible with protein assays. , 2006, Analytical biochemistry.
[20] S. Mundlos,et al. GDF5 is a second locus for multiple-synostosis syndrome. , 2006, American journal of human genetics.
[21] Stefan Mundlos,et al. Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2. , 2005, The Journal of clinical investigation.
[22] Joachim Nickel,et al. A single residue of GDF-5 defines binding specificity to BMP receptor IB. , 2005, Journal of molecular biology.
[23] F. Luyten,et al. Bone morphogenetic protein signaling in joint homeostasis and disease. , 2005, Cytokine & growth factor reviews.
[24] D. Ovchinnikov,et al. Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[25] W. Sebald,et al. Molecular recognition of BMP-2 and BMP receptor IA , 2004, Nature Structural &Molecular Biology.
[26] P. Knaus,et al. Signal transduction of bone morphogenetic protein receptors. , 2004, Cellular signalling.
[27] S. Mundlos,et al. Brachydactyly type C caused by a homozygous missense mutation in the prodomain of CDMP1 , 2004, American journal of medical genetics. Part A.
[28] S. Mundlos,et al. Mutations in bone morphogenetic protein receptor 1B cause brachydactyly type A2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[29] Markus Affolter,et al. Structural basis of BMP signalling inhibition by the cystine knot protein Noggin , 2002, Nature.
[30] L. Singh,et al. The mutational spectrum of brachydactyly type C. , 2002, American journal of medical genetics.
[31] Donna M. Martin,et al. Autosomal dominant stapes ankylosis with broad thumbs and toes, hyperopia, and skeletal anomalies is caused by heterozygous nonsense and frameshift mutations in NOG, the gene encoding noggin. , 2002, American journal of human genetics.
[32] M. Mangino,et al. Identification of a novel NOG gene mutation (P35S) in an Italian family with symphalangism , 2002, Human mutation.
[33] W Gaffield,et al. BMP and Ihh/PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation. , 2001, Development.
[34] C. Archer,et al. Growth/Differentiation Factor-5 (GDF-5) and Skeletal Development , 2001, The Journal of bone and joint surgery. American volume.
[35] T. Kirsch,et al. Crystal structure of the BMP-2–BRIA ectodomain complex , 2000, Nature Structural Biology.
[36] K. Lyons,et al. The type I BMP receptor BMPRIB is required for chondrogenesis in the mouse limb. , 2000, Development.
[37] C. Cremers,et al. Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis , 1999, Nature Genetics.
[38] C. Heldin,et al. Identification and Functional Characterization of a Smad Binding Element (SBE) in the JunB Promoter That Acts as a Transforming Growth Factor-β, Activin, and Bone Morphogenetic Protein-inducible Enhancer* , 1998, The Journal of Biological Chemistry.
[39] J. Massagué,et al. Distinct roles of type I bone morphogenetic protein receptors in the formation and differentiation of cartilage. , 1997, Genes & development.
[40] Frank P. Luyten,et al. Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1 , 1997, Nature Genetics.
[41] Clifford J. Tabin,et al. Regulation of Rate of Cartilage Differentiation by Indian Hedgehog and PTH-Related Protein , 1996, Science.
[42] N. Copeland,et al. Limb alterations in brachypodism mice due to mutations in a new member of the TGFβ-superfamily , 1994, Nature.
[43] Kohei Miyazono,et al. Bone morphogenetic protein receptors and signal transduction. , 2010, Journal of biochemistry.
[44] S. Mundlos,et al. Brachydactyly type A 2 associated with a defect in proGDF 5 processing , 2008 .
[45] J. Vane,et al. Optical Projection Tomography as a Tool for 3D Microscopy and Gene Expression Studies , 2002 .
[46] B. Morgan,et al. Manipulating gene expression with replication-competent retroviruses. , 1996, Methods in cell biology.
[47] J. T. Thomas,et al. Cartilage-derived morphogenetic proteins. New members of the transforming growth factor-beta superfamily predominantly expressed in long bones during human embryonic development. , 1994, The Journal of biological chemistry.